Standard Operating Procedure for Uniform Distribution of Active Ingredients in Gel Formulations
| Department | Gel Manufacturing |
|---|---|
| SOP No. | SOP/GM/028/2025 |
| Supersedes | SOP/GM/028/2022 |
| Page No. | Page 1 of 10 |
| Issue Date | 02/06/2025 |
| Effective Date | 04/06/2025 |
| Review Date | 02/06/2026 |
1. Purpose
The purpose of this SOP is to define a standardized procedure for achieving and verifying the uniform distribution of active pharmaceutical ingredients (APIs) within gel formulations during the manufacturing process.
2. Scope
This SOP applies to all batches of pharmaceutical gels manufactured in the Gel
Manufacturing Department where APIs must be uniformly distributed throughout the gel matrix.
3. Responsibilities
- Production Personnel: To ensure adherence to mixing parameters and record observations.
- Quality Assurance: To perform in-process checks and approve batch progression based on uniformity standards.
- Engineering: To maintain and calibrate mixing and homogenization equipment.
4. Accountability
The Head – Manufacturing is accountable for implementing this SOP and ensuring that all personnel involved are adequately trained and follow the procedure.
5. Procedure
5.1 Prerequisites
- Ensure the gel base is ready and all excipients have been properly mixed.
- Confirm that the batch manufacturing record (BMR) specifies the API concentration and mixing method.
- Verify the cleanliness and readiness of mixing equipment.
5.2 API Addition
- Weigh the required quantity of API as per the BMR using calibrated weighing balance.
- If necessary, pre-disperse the API in a suitable vehicle (e.g., purified water, propylene glycol) as per formulation instructions.
- Introduce the API gradually into the gel base under slow stirring (20–50 RPM) to prevent clumping or air entrapment.
5.3 Mixing Protocol
- Initiate mixing at low speed and gradually increase to the recommended RPM (typically 60–100 RPM).
- Continue mixing for the specified duration (typically 30–60 minutes or as mentioned in the BMR).
- Use a homogenizer (if applicable) for secondary mixing to achieve fine dispersion.
5.4 In-Process Checks
- Draw samples from different locations in the mixing vessel (top, middle, bottom).
- Perform in-process assay or content uniformity tests.
- If assay results vary beyond ±5% of target concentration, continue mixing or reprocess if necessary.
5.5 Post-Mixing Instructions
- Ensure complete dispersion visually (no clumps or sediment visible).
- Record the mixing time, speed, and observations in the BMR.
- Label the batch “Mixed” and forward it to the next step after QA approval.
6. Abbreviations
- API: Active Pharmaceutical Ingredient
- BMR: Batch Manufacturing Record
- RPM: Revolutions Per Minute
- QA: Quality Assurance
7. Documents
- Batch Manufacturing Record – Annexure-1
- API Addition Log – Annexure-2
- In-Process Uniformity Report – Annexure-3
8. References
- ICH Q8 – Pharmaceutical Development
- Schedule M – GMP for Pharmaceuticals
- Internal QA Guidelines on Content Uniformity
9. SOP Version
Version: 2.0
10. Approval Section
| Prepared By | Checked By | Approved By | |
|---|---|---|---|
| Signature | |||
| Date | |||
| Name | |||
| Designation | Jr. Production Chemist | QA Executive | Head – Manufacturing |
| Department | Gel Manufacturing | Quality Assurance | Manufacturing |
11. Annexures
Annexure-1: Batch Manufacturing Record
Detailed process steps and observations for each batch.
Annexure-2: API Addition Log
Log of API name, quantity, batch number, and time of addition.
Annexure-3: In-Process Uniformity Report
Sample testing results from different vessel locations.
Revision History:
| Revision Date | Revision No. | Details | Reason | Approved By |
|---|---|---|---|---|
| 01/05/2022 | 1.0 | Initial SOP | Initial implementation | QA Head |
| 02/06/2025 | 2.0 | Updated sampling and assay procedure | Process standardization | QA Head |